Introduction of imatinib as first-line therapy for chronic myeloid leukemia in Cuba.
Morán VP, Baute RG, Facundo JC, Ramírez PH, Núñez AA, Martínez EE, Cabrera OM, Padrón CH, Otero AG, Uría JC, Estrada EE, Díaz RM, Virgil AM, Sánchez KL, Cabeza AH.
Morán VP, et al. Among authors: padron ch.
MEDICC Rev. 2011 Jan;13(1):35-40. doi: 10.37757/MR2011V13.N1.9.
MEDICC Rev. 2011.
PMID: 21273957
Free article.
Clinical Trial.